Oscar Health (NYSE:OSCR) Trading Down 3.6% – Should You Sell?

Oscar Health, Inc. (NYSE:OSCR) was down 3.6% during mid-day trading on Friday . The company traded as low as $16.18 and last traded at $16.19. Approximately 2,941,235 shares traded hands during mid-day trading, a decline of 8% from the average daily volume of 3,204,464 shares. The stock had previously closed at $16.80.

Analyst Ratings Changes

A number of analysts have recently issued reports on OSCR shares. UBS Group started coverage on shares of Oscar Health in a research report on Monday, October 7th. They issued a “neutral” rating and a $23.00 price target for the company. Piper Sandler reissued an “overweight” rating and issued a $28.00 price target on shares of Oscar Health in a research report on Tuesday, September 10th. Three analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $24.00.

Oscar Health Stock Down 2.7 %

The business has a fifty day moving average of $19.00 and a 200 day moving average of $18.27. The stock has a market cap of $3.96 billion, a price-to-earnings ratio of -125.76, a P/E/G ratio of 34.83 and a beta of 1.62. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.91 and a quick ratio of 0.91.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.04. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The firm had revenue of $2.20 billion for the quarter, compared to the consensus estimate of $2.13 billion. During the same quarter in the prior year, the company posted ($0.07) earnings per share. The firm’s revenue was up 44.6% on a year-over-year basis. On average, equities analysts predict that Oscar Health, Inc. will post 0.01 earnings per share for the current year.

Insider Buying and Selling

In other Oscar Health news, insider Mario Schlosser sold 3,198 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $57,532.02. Following the transaction, the insider now owns 76,982 shares in the company, valued at $1,384,906.18. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other Oscar Health news, EVP Ranmali Bopitiya sold 36,175 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $650,788.25. Following the transaction, the executive vice president now owns 251,885 shares in the company, valued at $4,531,411.15. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Mario Schlosser sold 3,198 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $57,532.02. Following the completion of the sale, the insider now directly owns 76,982 shares of the company’s stock, valued at $1,384,906.18. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 169,569 shares of company stock worth $3,007,069. Insiders own 25.11% of the company’s stock.

Institutional Investors Weigh In On Oscar Health

Several hedge funds have recently modified their holdings of the business. Vanguard Group Inc. boosted its position in shares of Oscar Health by 2.4% in the first quarter. Vanguard Group Inc. now owns 14,582,762 shares of the company’s stock valued at $216,846,000 after acquiring an additional 337,850 shares during the period. Price T Rowe Associates Inc. MD boosted its position in shares of Oscar Health by 153.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock valued at $59,156,000 after acquiring an additional 2,409,160 shares during the period. Renaissance Technologies LLC lifted its position in Oscar Health by 31.7% in the second quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock worth $61,478,000 after purchasing an additional 934,600 shares during the period. First Light Asset Management LLC lifted its position in Oscar Health by 117.3% in the first quarter. First Light Asset Management LLC now owns 2,102,554 shares of the company’s stock worth $31,265,000 after purchasing an additional 1,134,919 shares during the period. Finally, Assenagon Asset Management S.A. lifted its position in Oscar Health by 32.9% in the second quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company’s stock worth $32,368,000 after purchasing an additional 507,009 shares during the period. 75.70% of the stock is owned by institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.